Emphysema

Lung Disease

Emphysema

What is Emphysema?

Emphysema is one of the major obstructive lung diseases under the chronic obstructive pulmonary disease (COPD) umbrella.  This lung condition gradually destroys the air sacs in the lungs, making it progressively more difficult to breathe. The tiny cluster-like air sacs in the lungs are responsible for bringing oxygen to the bloodstream. As emphysema progresses, the inner walls of the air sacs form holes, weakening their internal structure. The disease deters oxygen from reaching the bloodstream. Emphysema also destroys the elasticity of the airways that lead to the air sacs. As a result, the air sacs collapse, trapping oxygen in the lungs. Sufferers of emphysema constantly struggle to breathe.

Both Men and Women

Historically, men had developed emphysema more often than females. Starting in 2011, women have reported a higher rate of emphysema diagnosis than men.

Age

Older people are at a higher risk for developing emphysema. Emphysema is a progressive disease, which worsens over time and as you age, your physical health begins to decline. As a result of these two factors, older individuals are more likely to develop the disease.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

Related Posts

  • 6_great_foods_if_you_have_emphysemaWhen you have emphysema breathing can be difficult. Eating can become a challenge just to chew and breathe at the same time. Here is a list of five foods that ... Read more
  • Emphysema Prognosis After Quitting Smoking: What to ExpectIt’s important to know the facts about emphysema prognosis after quitting smoking. Keep reading to learn more about what to expect when you quit smoking. Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.